Transgenic plant and methods of stimulating spontaneous nodule formation in non-legume plants
US-2024384283-A1 · Nov 21, 2024 · US
US9783814B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9783814-B2 |
| Application number | US-201314384854-A |
| Country | US |
| Kind code | B2 |
| Filing date | Mar 12, 2013 |
| Priority date | Mar 13, 2012 |
| Publication date | Oct 10, 2017 |
| Grant date | Oct 10, 2017 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Genetic male sterile plants are provided in which complementing constructs result in suppression of a parental phenotype in the progeny. Methods to generate and maintain such plants and methods of use of said plants, are provided, including use of parental plants to produce sterile plants for hybrid seed production.
Opening claim text (preview).
What is claimed is: 1. A method for increasing yield or maintaining yield stability in a population of hybrid maize plants in a field, in the absence of detasseling, the method comprising: growing a population of male sterile hybrid maize plants that comprise a dominant mutation in a polynucleotide encoding a polypeptide comprising an amino acid sequence that is at least 95% identical to SEQ ID NO:14 or SEQ ID NO:153, the mutation causing male sterility, wherein said encoded polypeptide comprises Threonine or Valine corresponding to amino acid 37 of either SEQ ID NOs:14 or 153, wherein the population of male sterile hybrid maize plants are produced from a male sterile female maize plant containing the mutation, said male sterile female maize plant resulting from a fertile female inbred maize plant homozygous for the mutation, thereby increasing the yield compared to a control field that does not contain the male sterile hybrid maize plants. 2. The method of claim 1 , wherein the population of hybrid maize plants is grown under abiotic stress. 3. The method of claim 1 , wherein the population of hybrid maize plants is grown under a nitrogen limited condition. 4. The method of claim 1 , wherein the population of hybrid maize plants has as an agronomic parameter selected from the group consisting of increased silk emergence, increased ear length, increased ear width, increased seed number per ear, increased seed weight per ear, and seed with increased embryo size. 5. The method of claim 1 , wherein the polynucleotide comprises a mutation G to an A at position 118 relative to the first Met codon of SEQ ID NO: 13, resulting in an amino acid change at amino acid 37, from Alanine to Threonine that results in dominant genetic male sterility. 6. The method of claim 1 , wherein the polynucleotide encodes a polypeptide comprising the amino acid sequence of SEQ ID NO:14 or SEQ ID NO:153. 7. The method of claim 1 , wherein the polynucleotide is either SEQ ID NO:13 or SEQ ID NO:15. 8. The method of claim 1 , wherein the mutation is introduced into an endogenous polynucleotide of the plant. 9. A method of increasing maize yield in a field comprising a first population of hybrid maize plants which exhibit dominant male sterility conferred by a dominant mutation, in the absence of detasseling, the method comprising: growing a population of maize plants in the field, wherein the hybrid maize plants exhibiting dominant male sterility comprise a polynucleotide which comprises said mutation, said polynucleotide encoding a polypeptide comprising the amino acid sequence of either SEQ ID NO:14 or SEQ ID NO:153, or an amino acid sequence that is at least 95% identical to either SEQ ID NO:14 or SEQ ID NO:153, said polypeptide comprising Threonine or Valine corresponding to position 37 of SEQ ID NO:14 or SEQ ID NO:153, and wherein (a) the field further comprises a second population of maize plants that produce an effective amount of pollen to fertilize the first population of maize plants in the field, and (b) the hybrid maize plants are produced from a male sterile female maize plant containing the mutation, said male sterile female maize plant resulting from a fertile female inbred line homozygous for the mutation, thereby increasing the yield compared to a control field that does not contain the first population of plants. 10. The method of claim 9 , wherein the first population of plants is selected from the group consisting of maize plant populations which: a. comprises about 50% to about 90% of the maize plants in the field, b. comprises about 80% of the maize plants in the field, c. comprises about 75% of the maize plants in the field, d. comprises about 85% of the maize plants in the field, and e. comprises about 70% of the maize plants in the field.
from plants · CPC title
Male-specific, e.g. anther, tapetum, pollen · CPC title
Male sterility · CPC title
with agronomic (input) traits, e.g. crop yield · CPC title
for drought, cold, salt resistance · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.